A Study of Revumenib and Mezigdomide in People With Leukemia
Conditions
Leukemia · Acute Leukemia · Relapse Leukemia · Refractory Leukemia · Refractory Acute Leukemia · Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia · Mixed Phenotype Acute Leukemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope Cancer Center (Data collection only), Duarte, California, United States
Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States
Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack, New York, United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre, New York, United States
University of North Carolina (Data Collection Only), Chapel Hill, North Carolina, United States
MD Anderson Cancer Center (Data Collection Only), Houston, Texas, United States
Study leads
Kuo-Kai Chin, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center